Stock Events

Stock Events

Oxford BioDynamics 

$0
63
+$0+0% Thursday 13:30

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
101,000
Avg. Volume
-
Mkt Cap
6.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JunExpected
Q1 2023
Q4 2023
Q1 2024
Q4 2024
Q1 2025
Q3 2025
Next
-0.66
-0.33
0.01
0.34
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,018.95%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.91MRevenue
-29.69MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OXBOF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.63B
Illumina provides genomics solutions, competing in the broader market of genetic analysis and biomarker discovery, similar to Oxford BioDynamics' focus on biomarker research.
Pacific Biosciences of California
PACB
Mkt Cap496.78M
Pacific Biosciences offers long-read sequencing technologies, which are crucial for advanced biomarker and genomic research, directly competing with Oxford BioDynamics' epigenetic analysis technologies.
Qiagen NV
QGEN
Mkt Cap7.06B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the genomic and epigenomic analysis space.
Fulgent Genetics
FLGT
Mkt Cap407.57M
Fulgent Genetics focuses on genetic testing to provide comprehensive genetic information, competing with Oxford BioDynamics in the field of genetic and epigenetic analysis.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health is involved in cancer diagnostics through liquid biopsies, competing in the biomarker discovery and diagnostics market, similar to Oxford BioDynamics' focus.
Bionano Genomics
BNGO
Mkt Cap13.09M
Bionano Genomics provides tools for genomic analysis, including structural variant detection, competing in the genomics research space alongside Oxford BioDynamics.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is focused on gene editing, which requires detailed genomic analysis, a field where Oxford BioDynamics also operates by providing biomarker discovery services.
Intellia Therapeutics
NTLA
Mkt Cap1.58B
Intellia Therapeutics is another gene editing company that competes for the same genomic analysis market as Oxford BioDynamics, especially in the development of therapeutics.
Editas Medicine
EDIT
Mkt Cap283.93M
Editas Medicine is involved in gene editing and therapy, relying on genomic analysis technologies that compete with Oxford BioDynamics' offerings in biomarker and epigenetic research.

About

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Show more...
CEO
Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
Employees
51
Country
United Kingdom
ISIN
GB00BD5H8572

Listings

STU
DE
LMQ.STU
LSE
GB
OBD.LSE
F
DE
LMQ.F
OTC Link
US
OXBOF

0 Comments

Share your thoughts

FAQ

What is Oxford BioDynamics stock price today?▼
The current price of OXBOF is $0 USD — it has increased by +0% in the past 24 hours. Watch Oxford BioDynamics stock price performance more closely on the chart.
What is Oxford BioDynamics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Oxford BioDynamics stocks are traded under the ticker OXBOF.
What is Oxford BioDynamics market cap?▼
Today Oxford BioDynamics has the market capitalization of 6.85M
When is the next Oxford BioDynamics earnings date?▼
Oxford BioDynamics is going to release the next earnings report on June 23, 2026.
What is Oxford BioDynamics revenue for the last year?▼
Oxford BioDynamics revenue for the last year amounts to 2.91M USD.
What is Oxford BioDynamics net income for the last year?▼
OXBOF net income for the last year is -29.69M USD.
How many employees does Oxford BioDynamics have?▼
As of May 06, 2026, the company has 51 employees.
In which sector is Oxford BioDynamics located?▼
Oxford BioDynamics operates in the Health & Wellness sector.
When did Oxford BioDynamics complete a stock split?▼
Oxford BioDynamics has not had any recent stock splits.
Where is Oxford BioDynamics headquartered?▼
Oxford BioDynamics is headquartered in Oxford, United Kingdom.